New COVID-19 Cases Back to 2,000s...Capital Region Accounts for '73%' (Update)

Local Cases 2,014... Capital Region 1,476 'Record High'

On the 6th, amid the continued large-scale spread of COVID-19, citizens are waiting for testing at the temporary screening site in Seoul Station Plaza. According to the Central Disease Control Headquarters of the Korea Disease Control and Prevention Agency, as of midnight that day, the number of confirmed cases increased by 1,375 from the previous day to 261,778. The daily number of patients during the 4th wave has remained in the four digits for 62 consecutive days since July 7. Photo by Kim Hyun-min kimhyun81@

[Asia Economy Reporter Kim Ji-hee] The number of new COVID-19 cases in South Korea has exceeded 2,000 again after a week.

According to the Central Disease Control Headquarters, as of midnight on the 8th, the cumulative number of COVID-19 cases increased by 2,050 from the previous day, reaching a total of 265,423. In terms of infection routes, 2,014 cases were locally transmitted, and 36 were imported from overseas.

In the metropolitan area, local cases were recorded as 665 in Seoul, 691 in Gyeonggi, and 120 in Incheon, totaling 1,476. Metropolitan area cases accounted for 73.3% of the total. In non-metropolitan areas, cases were reported as 84 in Chungnam, 69 in Gyeongnam, 60 in Daegu, 39 in Daejeon, 33 in Gangwon, 31 in Busan, 30 in Jeonbuk, 24 in Gyeongbuk, 22 in Jeonnam, 8 in Jeju, and 7 in Sejong.

The total number of tests conducted in one day exceeded 140,000. At temporary screening clinics set up in the metropolitan area, 77,988 tests were conducted, confirming 486 positive cases, while 16,403 tests were conducted at temporary screening clinics in non-metropolitan areas, confirming 88 positive cases.

The number of critically ill patients increased by 23 from the previous day to 387. The cumulative death toll rose by 4 to 2,334.

Meanwhile, according to the COVID-19 Vaccination Response Promotion Team, 573,321 people newly received their first vaccine dose the previous day. The cumulative number of first-dose recipients is 31,323,194. The first-dose vaccination rate reached 61%. Additionally, 420,18 people newly completed their vaccination, bringing the total number of fully vaccinated individuals to 18,807,546, with a vaccination completion rate of 36.6% of the population.

Cases reported as suspected adverse reactions after vaccination increased by 8,165 over two days, surpassing a cumulative total of 200,000. Symptoms commonly occurring after vaccination, such as muscle pain, headache, fever, chills, and nausea, accounted for 192,112 cases (95.7%) of the total. Among newly reported adverse reaction cases, there were 41 suspected anaphylaxis cases, 223 neurological adverse reactions, and 18 deaths.

This content was produced with the assistance of AI translation services.